We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

X-Ray Crystallography Reveals Structure of the Arenavirus Binding Complex

By LabMedica International staff writers
Posted on 11 May 2016
Print article
Image: The structure gives scientists a new view of Lymphocytic choriomeningitis mammarenavirus (LCMV), a close relative of the Lassa fever virus (Photo courtesy of the Ollmann Saphire Laboratory, The Scripps Research Institute).
Image: The structure gives scientists a new view of Lymphocytic choriomeningitis mammarenavirus (LCMV), a close relative of the Lassa fever virus (Photo courtesy of the Ollmann Saphire Laboratory, The Scripps Research Institute).
A team of molecular virologists has established the three-dimensional structure of the intensely studied research tool, Lymphocytic choriomeningitis mammarenavirus (LCMV).

LCMV and the closely related, but much deadlier Lassa fever virus are arenaviruses, which exist worldwide and cause hemorrhagic fevers and neurological disease. These viruses are characterized by a single glycoprotein expressed on the viral surface that mediates entry into target cells. This glycoprotein, termed GPC, contains a membrane-associated signal peptide, a receptor-binding subunit termed GP1, and a fusion-mediating subunit termed GP2. Although GPC is a critical target of antibodies and vaccines, the structure of the metastable GP1-GP2 prefusion complex has remained undetermined for all arenaviruses.

When LCMV attacks a cell, attachment of the virus to host receptors through its surface glycoproteins initiates the process of replication. The virus is encapsulated into a vesicle inside the host cell, which creates a fusion of the virus and vesicle membranes. The viral ribonucleocapsid is then released into the cytoplasm of the host cell. The RNA-dependent, RNA-polymerase brought along with the virus initially binds to a promoter and begins transcription from negative-stranded to a positive-stranded mRNA. The formation of a strong hairpin sequence at the end of each gene terminates transcription. The mRNA strands are capped by the RNA-dependent, RNA-polymerase in the cytoplasm and are then subsequently translated into the four proteins essential for LCMV assembly. The ribonucleocapsid interacts with the Z matrix protein and buds on the cell membrane, releasing the virion to exit the infected cell.

In a paper published in the April 25, 2016, online edition of the journal Nature Structural & Molecular Biology, investigators at The Scripps Research Institute (La Jolla, CA, USA) described results of a long-term X-ray crystallography study that elucidated the crystal structure of the fully glycosylated prefusion GP1-GP2 complex of LCMV at a resolution of .35 nm.

The "double dimer" structure that was obtained revealed the conformational changes that the arenavirus glycoprotein must undergo to cause fusion and illustrated the fusion regions and potential oligomeric states.

"LCMV has been a beacon that has illuminated immunology and virology for decades," said senior author Dr. Erica Ollmann Saphire, professor of immunology and microbial science at The Scripps Research Institute. "This structure provides the missing roadmap to understand how to defend against its extremely lethal cousin, Lassa virus. It has moving parts. LCMV now looks like it sits between class I and class II viruses, making this structure a possible "fossil" of an intermediate evolutionary process."

Related Links:
The Scripps Research Institute

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.